Susquehanna International Group’s Allena Pharmaceuticals ALNA Stock Holding History

Susquehanna International Group’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-65,789	Closed	-$13K	–	14740
2022 Q2	$13K	Buy	65,789 +7,388	+13%	+$1.14K	﹤0.01%	12471
2022 Q1	$14K	Buy	58,401 +43,532	+293%	+$18K	﹤0.01%	12709
2021 Q4	$9K	Buy	14,869 +530	+4%	+$414	﹤0.01%	12947
2021 Q3	$13K	Buy	+14,339	New	+$14K	﹤0.01%	12592
2019 Q3	–	Sell	-33,565	Closed	-$137K	–	11066
2019 Q2	$137K	Buy	+33,565	New	+$183K	﹤0.01%	9436

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Susquehanna International Group's ALNA Position: Q3 2022 in Review

Susquehanna International Group sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 65,789 shares — an estimated $13K sold.

Susquehanna International Group first reported a position in ALNA in Q2 2019 and held it in 5 quarters. The position peaked at $137K in Q2 2019. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Susquehanna International Group reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Susquehanna International Group sold 65,789 Allena Pharmaceuticals shares in Q3 2022, an estimated $13K.
Susquehanna International Group first reported a position in Allena Pharmaceuticals in Q2 2019 and held it in 5 quarters.
Susquehanna International Group's Allena Pharmaceuticals position peaked at $137K in Q2 2019.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.